OTCMKTS:MRMD MariMed (MRMD) Stock Price, News & Analysis → Claim Your Complimentary Bitcoin Reward (From Crypto Swap Profits) (Ad) Free MRMD Stock Alerts $0.26 -0.01 (-4.58%) (As of 05/10/2024 08:56 PM ET) Add Compare Share Share Today's Range$0.26▼$0.2950-Day Range$0.20▼$0.3252-Week Range$0.20▼$0.55Volume199,100 shsAverage Volume455,704 shsMarket Capitalization$98.47 millionP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort InterestStock AnalysisChartEarningsFinancialsHeadlinesSEC FilingsShort Interest Get MariMed alerts: Email Address Ad Crypto Swap ProfitsDid You Get Your Free Bitcoin Yet?And my special guest is willing to give you $10 in Bitcoin (BTC) if you take it seriously. Right now is a very important time to pay attention to what we are doing and what is happening. If you wait... it will be too late. This week we are holding several workshops and if you attend and pay attention my special guest is going to send you $10 in Bitcoin.>> Register right here About MariMed Stock (OTCMKTS:MRMD)MariMed Inc. engages in cultivation, production, and dispensing of medicinal and recreational cannabis in the United States and internationally. The company sells flowers and concentrates under the Nature's Heritage brand; and soft and chewy baked goods and a hot chocolate mix under Bubby's Baked brand; and drink mix under Vibations brand. It also offers chewable cannabis-infused mint tablet under the brand Kalm Fusion; and flower, vapes, and edibles under InHouse brand. In addition, the company provides supplement, nutrient-infused fruit chews under Betty's Eddies brand and ice creams under Emack & Bolio's brand. The company licenses its brands. MariMed Inc. was incorporated in 2011 and is based in Norwood, Massachusetts.Read More MRMD Stock Price History View Price History Chart DataSkip Price History Chart 30 days | 90 days | 365 days | Advanced Chart MRMD Stock News HeadlinesMay 10, 2024 | finance.yahoo.comMariMed Inc. (PNK:MRMD) Q1 2024 Earnings Call TranscriptMay 9, 2024 | markets.businessinsider.comAnalysts Are Bullish on These Healthcare Stocks: MariMed (MRMD), Trevi Therapeutics (TRVI)May 13, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.May 9, 2024 | finanznachrichten.deMariMed Inc.: MariMed Reports First Quarter 2024 EarningsMay 9, 2024 | msn.comMRMD Stock Earnings: MariMed Beats Revenue for Q1 2024May 9, 2024 | msn.comQ1 2024: MariMed's Revenue Rises To $37.9M, Amid Declining Gross MarginMay 9, 2024 | markets.businessinsider.comQ1 2024: MariMed's Revenue Rises To $37.9M, Shrinks Losses While Increasing Wholesale RevenueMay 8, 2024 | globenewswire.comMariMed Reports First Quarter 2024 EarningsMay 13, 2024 | Crypto Swap Profits (Ad)Claim Your Complimentary Bitcoin RewardMany have already secured their free Bitcoin reward offered by our esteemed guest. How about you? In an effort to spread the word about our upcoming workshop, he's generously offering $10 in Bitcoin (BTC) to participants. Absolutely no strings attached.May 8, 2024 | americanbankingnews.comMariMed (OTCMKTS:MRMD) Shares Up 1.9%April 30, 2024 | msn.comCannabis Industry Leaders React To DEA's Historic Move To Reschedule CannabisApril 30, 2024 | finance.yahoo.comStatement From MariMed CEO And President Jon Levine Regarding The Drug Enforcement Administration’s Decision To Recategorize Cannabis To Schedule IIIApril 30, 2024 | globenewswire.comStatement From MariMed CEO And President Jon Levine Regarding The Drug Enforcement Administration's Decision To Recategorize Cannabis To Schedule IIIApril 26, 2024 | finance.yahoo.comMariMed closes acquisition of a dispensary in Illinois marking the company’s 5th in that stateApril 21, 2024 | msn.comCannabis Investors Share 'Chips Make Chunks' Wisdom For Business Expansion At Benzinga ConferenceApril 17, 2024 | benzinga.com'A F—ed-Up Situation,' Says MariMed CCO About How State Regulations Complicate Cannabis Edibles StrategyApril 13, 2024 | uk.investing.comMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois DispensaryApril 11, 2024 | msn.comMariMed Is On A Roll: Partners With Two Iconic Music Venues In Boston, Acquires Another Illinois Cannabis DispensaryApril 11, 2024 | finance.yahoo.comMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois DispensaryApril 11, 2024 | finance.yahoo.comMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company’s Fifth Illinois DispensaryApril 11, 2024 | globenewswire.comMariMed Closes Acquisition of Thrive Dispensary in Casey, The Company's Fifth Illinois DispensaryApril 10, 2024 | bizjournals.comMass. cannabis firm sponsors MGM Music Hall, House of BluesApril 10, 2024 | globenewswire.comMariMed Partners with Iconic Boston Music VenuesApril 10, 2024 | globenewswire.comMariMed Partners with Iconic Boston Music VenuesApril 9, 2024 | finanznachrichten.deMariMed Inc.: MariMed Closes Acquisition of Second Maryland DispensaryApril 9, 2024 | globenewswire.comMariMed Closes Acquisition of Second Maryland DispensaryApril 8, 2024 | globenewswire.comMariMed Announces First Quarter 2024 Earnings DateSee More Headlines Receive MRMD Stock News and Ratings via Email Sign-up to receive the latest news and ratings for MariMed and its competitors with MarketBeat's FREE daily newsletter. Email Address Company Calendar Last Earnings11/15/2021Today5/12/2024Fiscal Year End12/31/2024Get Stock AlertsIndustry, Sector and Symbol Stock ExchangeOTCMKTS SectorMedical Industry Medicinals & botanicals Sub-IndustryN/A Current SymbolOTCMKTS:MRMD CUSIPN/A CIK1522767 Webmarimedadvisors.com Phone(617) 795-5140FaxN/AEmployees643Year FoundedN/AProfitability EPS (Most Recent Fiscal Year)($0.04) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-16,030,000.00 Net Margins-10.97% Pretax Margin-4.44% Return on Equity-2.68% Return on Assets-1.07% Debt Debt-to-Equity Ratio0.97 Current Ratio1.67 Quick Ratio0.85 Sales & Book Value Annual Sales$148.60 million Price / Sales0.66 Cash Flow$0.03 per share Price / Cash Flow9.14 Book Value$0.19 per share Price / Book1.38Miscellaneous Outstanding Shares375,130,000Free Float298,041,000Market Cap$98.47 million OptionableNot Optionable Beta2.75 A Guide To High-Short-Interest StocksMarketBeat's analysts have just released their top five short plays for May 2024. Learn which stocks have the most short interest and how to trade them. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Jon R. Levine (Age 59)Co-Founder, CEO, Interim CFO, President, Secretary, Treasurer & Director Comp: $390.5kMr. Timothy Shaw (Age 46)Chief Operating Officer Comp: $346.62kMr. Jonathan W. Rider (Age 59)Chief Information Officer Mr. Steve Wayne WestVice President of Investor RelationsMr. Howard SchacterChief Communications OfficerMr. Ryan CrandallChief Revenue OfficerMr. Charles Holt FinnieChief Strategy OfficerMore ExecutivesKey CompetitorsJushiOTCMKTS:JUSHFFitLife BrandsNASDAQ:FTLFBright GreenNASDAQ:BGXXMediWoundNASDAQ:MDWDNatural Alternatives InternationalNASDAQ:NAIIView All Competitors MRMD Stock Analysis - Frequently Asked Questions How have MRMD shares performed in 2024? MariMed's stock was trading at $0.2748 at the beginning of the year. Since then, MRMD stock has decreased by 4.5% and is now trading at $0.2625. View the best growth stocks for 2024 here. Are investors shorting MariMed? MariMed saw a decline in short interest during the month of April. As of April 30th, there was short interest totaling 8,500 shares, a decline of 44.4% from the April 15th total of 15,300 shares. Based on an average trading volume of 571,000 shares, the days-to-cover ratio is presently 0.0 days. View MariMed's Short Interest. How were MariMed's earnings last quarter? MariMed Inc. (OTCMKTS:MRMD) released its earnings results on Monday, November, 15th. The company reported $0.01 earnings per share (EPS) for the quarter. The firm earned $33.21 million during the quarter. MariMed had a negative net margin of 10.97% and a negative trailing twelve-month return on equity of 2.68%. What guidance has MariMed issued on next quarter's earnings? MariMed issued an update on its FY 2024 earnings guidance on Wednesday, May, 8th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $156.0 million-$159.0 million, compared to the consensus revenue estimate of $157.4 million. What other stocks do shareholders of MariMed own? Based on aggregate information from My MarketBeat watchlists, some companies that other MariMed investors own include KushCo (KSHB), Organigram (OGI), Auxly Cannabis Group (CBWTF), CNBX Pharmaceuticals (CNBX), Supreme Cannabis (SPRWF), Pennsylvania Real Estate Investment Trust (PEI), GB Sciences (GBLX), Medical Marijuana (MJNA) and Smart Cannabis (SCNA). How do I buy shares of MariMed? Shares of MRMD stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. Compare Top Brokerages Here. This page (OTCMKTS:MRMD) was last updated on 5/13/2024 by MarketBeat.com Staff From Our PartnersThe Department of Defense Has a New Drone ContractorThe Tomorrow InvestorHe Is Giving Away BitcoinCrypto Swap ProfitsThe Crypto 9-5 Escape PlanCrypto 101 MediaElon’s New Device is About to Shock the WorldInvestorPlaceThe A.I. story nobody is telling you (Read ASAP)TradeSmithObama’s Forever Term [exposed]Porter & CompanyThe “Next Bitcoin”? 10 CENT Crypto Set to ExplodeTrue Market InsidersUrgent Nvidia WarningAltimetry Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding MariMed Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.